Novel positioning of Olea europaea L. (Olive) from farm to pharma indexed in pharmacopeia

IP Journal of Nutrition, Metabolism and Health Science 2023, 6(4):161-170. http://doi.org/10.18231/j.ijnmhs.2023.027

IP Journal of Nutrition, Metabolism and Health Science, volume 6, issue 4, 2024 [10.18231/j.ijnmhs.2023.027]

IP Journal of Nutrition, Metabolism and Health Science, volume 6, issue 4, 2024 [10.18231/j.ijnmhs.2023.027]

10 Pages Posted: 30 Nov 2023 Last revised: 28 Feb 2024

See all articles by Afreen Usmani

Afreen Usmani

Umapati Mahadev College of Pharmacy, Amroha 244221 UP, India

Rania I.M. Almoselhy

Food Technology Research Institute (FTRI) – Agricultural Research Center (ARC) – Giza – Egypt.

Date Written: February 15, 2024

Abstract

The current study explores the transformative journey of Olea europaea L. (Olive) from its traditional role in random traditional medicine to its current positioning in pharmacopeia as a pharmaceutical preparation with defined dosage and indications. The comprehensive examination covers botanical and chemical profiles, traditional uses, pharmacological activities, extraction techniques, quality control, regulatory status, clinical studies, and future directions. Various analytical methods, including spectroscopic and chromatographic approaches, are discussed for quality evaluation and detection of adulteration. Additionally, the regulatory landscape, particularly within the European Union, is outlined, emphasizing the importance of accurate labeling and geographical origin disclosure. The regulatory status of Olea europaea L. varies across regions, ranging from restrictions due to safety concerns to inclusion in pharmacopeias as traditional herbal medicine or pharmaceutical preparations. A pivotal development highlighted is the incorporation of Olive into Egyptian pharmacopeia, signifying a significant shift towards evidence-based therapy and reinforcing its acceptance in mainstream healthcare.

Note:

Funding Information: This research received no external funding.

Conflict of Interests: The authors declare no conflict of interest.

Keywords: Olea europaea L.; Olive; Extra virgin olive oil; Olive leaf; Medicinal plants; Pharmacopeia; Herbal monograph; Egyptian Drug Authority (EDA); Traditional medicine; Therapeutic nutrition

JEL Classification: Q1

Suggested Citation

Usmani, Afreen and Almoselhy, Rania I.M., Novel positioning of Olea europaea L. (Olive) from farm to pharma indexed in pharmacopeia (February 15, 2024). IP Journal of Nutrition, Metabolism and Health Science 2023, 6(4):161-170. http://doi.org/10.18231/j.ijnmhs.2023.027 , IP Journal of Nutrition, Metabolism and Health Science, volume 6, issue 4, 2024 [10.18231/j.ijnmhs.2023.027], IP Journal of Nutrition, Metabolism and Health Science, volume 6, issue 4, 2024 [10.18231/j.ijnmhs.2023.027], Available at SSRN: https://ssrn.com/abstract=4632122 or http://dx.doi.org/10.18231/j.ijnmhs.2023.027

Afreen Usmani

Umapati Mahadev College of Pharmacy, Amroha 244221 UP, India ( email )

Amroha
India

Rania I.M. Almoselhy (Contact Author)

Food Technology Research Institute (FTRI) – Agricultural Research Center (ARC) – Giza – Egypt. ( email )

9 Al Gamaa Street - Giza
Giza 12619
Egypt
+202 35723000 / +202 35723001 (Phone)
+202 35722609 (Fax)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
81
Abstract Views
399
Rank
622,688
PlumX Metrics